Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carbomedics, historically known as Sulzer Carbomedics, is a leading medical technology company focused on the development of mechanical heart valves and cardiovascular prostheses. The company gained international recognition for its proprietary pyrolytic carbon technology, which significantly improved the longevity and performance of bileaflet mechanical valves. Based in Austin, Texas, Carbomedics operated as a core component of Sulzer Medica's cardiovascular division before its acquisition by the Sorin Group in 2003. Its products, including the Carbomedics Bileaflet Heart Valve, remain widely used in cardiac surgery for the treatment of aortic and mitral valve diseases. Currently, the company's legacy and technology continue under the umbrella of LivaNova.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sulzer Carbomedics.